Correlation Between Verde Bio and Rafarma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Verde Bio and Rafarma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verde Bio and Rafarma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verde Bio Holdings and Rafarma Pharmaceuticals, you can compare the effects of market volatilities on Verde Bio and Rafarma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verde Bio with a short position of Rafarma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verde Bio and Rafarma Pharmaceuticals.
Diversification Opportunities for Verde Bio and Rafarma Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Verde and Rafarma is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Verde Bio Holdings and Rafarma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rafarma Pharmaceuticals and Verde Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verde Bio Holdings are associated (or correlated) with Rafarma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rafarma Pharmaceuticals has no effect on the direction of Verde Bio i.e., Verde Bio and Rafarma Pharmaceuticals go up and down completely randomly.
Pair Corralation between Verde Bio and Rafarma Pharmaceuticals
If you would invest 5.50 in Rafarma Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 3.20 from holding Rafarma Pharmaceuticals or generate 58.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 98.46% |
| Values | Daily Returns |
Verde Bio Holdings vs. Rafarma Pharmaceuticals
Performance |
| Timeline |
| Verde Bio Holdings |
| Rafarma Pharmaceuticals |
Verde Bio and Rafarma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verde Bio and Rafarma Pharmaceuticals
The main advantage of trading using opposite Verde Bio and Rafarma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verde Bio position performs unexpectedly, Rafarma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rafarma Pharmaceuticals will offset losses from the drop in Rafarma Pharmaceuticals' long position.| Verde Bio vs. USCorp | Verde Bio vs. Trimax Corp | Verde Bio vs. CLST Holdings | Verde Bio vs. Coastal Capital Acq |
| Rafarma Pharmaceuticals vs. Holloman Energy Corp | Rafarma Pharmaceuticals vs. cbdMD Inc | Rafarma Pharmaceuticals vs. Evolus Inc | Rafarma Pharmaceuticals vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |